Sat, Sep 20, 2014, 3:03 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Sangamo Biosciences Inc. Message Board

  • hwmccusker hwmccusker May 24, 2013 9:08 AM Flag

    $6.4 M from CIRM – BUY

    The Bottom Line: Adding to our coverage list as SGMO’s ZFN-genome editing technology enables modification of a patient’s own stem cells and potentially provides a safer approach to current therapies for hemoglobinopathies such as beta-thalassemia and sickle cell disease. the persistence of fetal hemoglobin beyond the newborn stage mitigates the severity of these hemoglobin disorders. If successful, this could eliminate the need for life-long medications and red blood cell transfusions that are currently the standard of care for these disorders.”
    SGMO closed on 5/23/13 at $7.43 on a low volume day and had traded as high as $10.80 on 5/3/13. This is definitely an actionable event and I project a $0.10 to $0.20 jump for SGMO even in a DOWN and vacation weekend market on the non-dilutive CIRM funding – it might even spill over into Tuesday. The 50 day moving average is $9.28 followed by the 200 at a low of $8.10.

    Sentiment: Buy

11.445-0.295(-2.51%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.